Dr. Michael Verni, MD

Claim this profile

Urology Center

Studies Bladder Cancer
Studies Transitional Cell Carcinoma
3 reported clinical trials
3 drugs studied

Area of expertise

1

Bladder Cancer

Michael Verni, MD has run 2 trials for Bladder Cancer. Some of their research focus areas include:

Stage II
Stage I
2

Transitional Cell Carcinoma

Michael Verni, MD has run 2 trials for Transitional Cell Carcinoma. Some of their research focus areas include:

Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

Urology Center

Image of trial facility.

Urology Center Las Vegas

More about Michael Verni, MD

Clinical Trial Related

4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Michael Verni, MD has experience with

  • UGN-102
  • ProstAtak® Immunotherapy
  • TURBT

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Michael Verni, MD specialize in?

Is Michael Verni, MD currently recruiting for clinical trials?

Are there any treatments that Michael Verni, MD has studied deeply?

What is the best way to schedule an appointment with Michael Verni, MD?

What is the office address of Michael Verni, MD?

Is there any support for travel costs?